Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.

Nasdaq · CIK 0001877184
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end0430
XBRL facts210

Identity from submissions API

NameKESTRA MEDICAL TECHNOLOGIES, LTD.
CIK0001877184
TickersKMTS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN000000000
LEI—
Fiscal year end0430
State of incorporationD0 Bermuda
Phone(425) 279-8002
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3933 LAKE WASHINGTON BLVD NE
SUITE 200
KIRKLAND
WA
98033
WA
Mailing address
3933 LAKE WASHINGTON BLVD NE
SUITE 200
KIRKLAND
WA
98033
WA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

189 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468555 7080
2026-11-18 144 xsl144X01/primary_doc.xml 0001964306-26-000518 001-42549 261570591 33 9067
2026-11-05 4 4 0001193125-26-450260 5450
2026-11-03 144 xsl144X01/primary_doc.xml 0001964306-26-000494 001-42549 261517531 33 6391
2026-10-29 4 4 0001193125-26-438722 19803
2026-10-29 4 4 0001193125-26-438662 8927
2026-10-29 144 xsl144X01/primary_doc.xml 0001964306-26-000483 001-42549 261502443 33 9020
2026-10-28 144 xsl144X01/primary_doc.xml 0001964306-26-000479 001-42549 261496345 33 8375
2026-10-27 144 xsl144X01/primary_doc.xml 0001964306-26-000477 001-42549 261490613 33 7727
2026-10-27 144 xsl144X01/primary_doc.xml 0001964306-26-000476 001-42549 261490469 33 7743
2026-10-22 4 4 0001193125-26-428980 10748
2026-10-22 4 4 0001193125-26-428976 7302
2026-10-21 144 xsl144X01/primary_doc.xml 0001964306-26-000473 001-42549 261475682 33 7097
2026-10-20 144 xsl144X01/primary_doc.xml 0001964306-26-000472 001-42549 261472670 33 8420
2026-10-01 4 4 0001193125-26-410928 5424
2026-09-30 144 xsl144X01/primary_doc.xml 0001964306-26-000458 001-42549 261427218 33 4457
2026-09-23 4 4 0001193125-26-399696 5415
2026-09-21 144 xsl144X01/primary_doc.xml 0001964306-26-000452 001-42549 261393827 33 4450
2026-09-14 10-Q 10-Q 0001193125-26-390766 001-42549 261378273 34 9064562 1 1
2026-09-14 8-K 8-K 2.02,9.01 0001193125-26-390535 001-42549 261377336 34 729571 1 1
2026-09-10 4 4 0000950130-26-000223 8277
2026-09-10 4 4 0001193125-26-388308 5006
2026-09-10 4 4 0001193125-26-388306 5008
2026-09-10 4 4 0001193125-26-388302 58486
2026-09-10 4 4 0001193125-26-388298 7082
2026-09-10 4 4 0001193125-26-388297 7302
2026-09-10 8-K 8-K 5.07 0001193125-26-388057 001-42549 261371982 34 185293 1 1
2026-09-08 144 xsl144X01/primary_doc.xml 0000950130-26-000219 001-42549 261366250 33 4469
2026-09-08 144 xsl144X01/primary_doc.xml 0001964306-26-000431 001-42549 261365229 33 4451
2026-09-08 144 xsl144X01/primary_doc.xml 0001964306-26-000430 001-42549 261365211 33 4426
2026-09-08 144 xsl144X01/primary_doc.xml 0001964306-26-000429 001-42549 261365192 33 4411
2026-08-18 4 4 0001193125-26-355847 5378
2026-08-17 144 xsl144X01/primary_doc.xml 0001964306-26-000397 001-42549 261287377 33 9719
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000587 005-95012 261277444 34 7836
2026-08-11 4 4 0001193125-26-345169 7044
2026-08-07 144 xsl144X01/primary_doc.xml 0001964306-26-000372 001-42549 261254017 33 7102
2026-08-06 4 4 0001193125-26-338668 5408
2026-08-06 4 4 0001193125-26-338665 7354
2026-08-06 4 4 0001193125-26-338659 5435
2026-08-06 4 4 0001193125-26-338657 9072
2026-08-04 144 xsl144X01/primary_doc.xml 0001964306-26-000364 001-42549 261239458 33 8963
2026-08-04 144 xsl144X01/primary_doc.xml 0001964306-26-000363 001-42549 261239384 33 6354
2026-08-04 144 xsl144X01/primary_doc.xml 0001964306-26-000362 001-42549 261239361 33 6346
2026-08-04 144 xsl144X01/primary_doc.xml 0001964306-26-000361 001-42549 261239283 33 6345
2026-08-03 4 4 0001193125-26-331066 9084
2026-08-03 4 4 0001193125-26-331065 9046
2026-08-03 4 4 0001193125-26-331062 9034
2026-08-03 4 4 0001193125-26-331061 9071
2026-08-03 4 4 0001193125-26-331055 9073
2026-08-03 144 xsl144X01/primary_doc.xml 0001964306-26-000360 001-42549 261233801 33 5703
2026-08-03 144 xsl144X01/primary_doc.xml 0001964306-26-000359 001-42549 261233756 33 5699
2026-08-03 144 xsl144X01/primary_doc.xml 0001964306-26-000358 001-42549 261233740 33 5710
2026-08-03 144 xsl144X01/primary_doc.xml 0001964306-26-000357 001-42549 261233717 33 5747
2026-08-03 144 xsl144X01/primary_doc.xml 0001964306-26-000356 001-42549 261233698 33 8316
2026-07-31 144 xsl144X01/primary_doc.xml 0001964306-26-000343 001-42549 261229059 33 5056
2026-07-31 144 xsl144X01/primary_doc.xml 0001964306-26-000342 001-42549 261229017 33 5053
2026-07-31 144 xsl144X01/primary_doc.xml 0001964306-26-000341 001-42549 261228933 33 5064
2026-07-31 144 xsl144X01/primary_doc.xml 0001964306-26-000339 001-42549 261228916 33 5103
2026-07-31 144 xsl144X01/primary_doc.xml 0001964306-26-000338 001-42549 261228864 33 7667
2026-07-30 144 xsl144X01/primary_doc.xml 0001964306-26-000337 001-42549 261223994 33 4458
2026-07-30 144 xsl144X01/primary_doc.xml 0001964306-26-000336 001-42549 261223986 33 7021
2026-07-30 144 xsl144X01/primary_doc.xml 0001964306-26-000335 001-42549 261223952 33 4418
2026-07-30 144 xsl144X01/primary_doc.xml 0001964306-26-000334 001-42549 261223895 33 4411
2026-07-30 144 xsl144X01/primary_doc.xml 0001964306-26-000333 001-42549 261223837 33 4407
2026-07-28 ARS ARS 0001193125-26-321012 001-42549 261211972 34 1776712
2026-07-28 DEFA14A DEFA14A 0001193125-26-320985 001-42549 261211856 34 1652815
2026-07-28 DEF 14A DEF 14A 0001193125-26-320956 001-42549 261211783 34 3172779 1 1
2026-07-17 4 4 0001193125-26-308047 5017
2026-07-17 4 4 0001193125-26-308046 4976
2026-07-17 4 4 0001193125-26-308045 4967
2026-07-17 4 4 0001193125-26-308044 5002
2026-07-17 4 4 0001193125-26-308041 10922
2026-07-15 144 xsl144X01/primary_doc.xml 0001964306-26-000320 001-42549 261177597 33 6530
2026-07-14 10-K 10-K 0001193125-26-303397 001-42549 261175035 34 15076511 1 1
2026-07-14 8-K 8-K 1.01,1.02,2.02,2.03,9.01 0001193125-26-303169 001-42549 261174365 34 851918 1 1
2026-07-02 4 4 0001193125-26-294959 5448
2026-07-02 4 4 0001193125-26-294955 5434
2026-06-17 4 4 0001193125-26-274257 5378
2026-06-15 144 xsl144X01/primary_doc.xml 0001964306-26-000289 001-42549 261091872 33 7174
2026-06-04 4 4 0001193125-26-257915 5078
2026-06-04 4 4 0001193125-26-257913 5016
2026-06-04 4 4 0001193125-26-257911 5227
2026-06-04 4 4 0001193125-26-257908 5063
2026-06-04 4 4 0001193125-26-257907 5067
2026-05-18 4 4 0001193125-26-229188 7305
2026-05-15 144 xsl144X01/primary_doc.xml 0001964306-26-000243 001-42549 26987759 33 6526
2026-04-16 4 4 0001193125-26-159276 5377
2026-04-15 144 xsl144X01/primary_doc.xml 0001964306-26-000204 001-42549 26864369 33 6526
2026-04-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000314 005-95012 26847841 34 7801
2026-04-01 S-3ASR S-3ASR 0001193125-26-138030 333-294825 26828745 33 490025 1 1
2026-03-30 4 4 0001193125-26-132324 5070
2026-03-19 4 4 0001193125-26-115983 5306
2026-03-18 S-8 S-8 0001193125-26-111339 333-294390 26763912 33 200334 1 1
2026-03-17 144 xsl144X01/primary_doc.xml 0001964306-26-000183 001-42549 26763969 33 6526
2026-03-17 10-Q 10-Q 0001193125-26-111205 001-42549 26763460 34 9477406 1 1
2026-03-17 8-K 8-K 2.02,9.01 0001193125-26-110720 001-42549 26761719 34 712021 1 1
2026-03-12 4 4 0001193125-26-104188 21601
2026-02-19 4 4 0001193125-26-059532 9096
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950130-26-000088 005-95012 26642121 34 7535
2026-02-17 144 xsl144X01/primary_doc.xml 0001964306-26-000104 001-42549 26640969 33 5879
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054535 005-95012 26640601 34 11302
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000080255-26-000287 005-95012 26637717 34 7588
2026-01-20 4 4 0001193125-26-015862 5166
2026-01-15 144 xsl144X01/primary_doc.xml 0001964306-26-000046 001-42549 26536502 33 5232
2025-12-31 4 4 0001193125-25-338326 5370
2025-12-31 4 4 0001193125-25-338322 5373
2025-12-29 144 xsl144X01/primary_doc.xml 0001964306-25-000457 001-42549 251609657 33 4517
2025-12-29 144 xsl144X01/primary_doc.xml 0001964306-25-000456 001-42549 251609648 33 4586
2025-12-11 10-Q 10-Q 0001193125-25-316210 001-42549 251565781 34 8940575 1 1
2025-12-11 8-K 8-K 2.02,9.01 0001193125-25-315896 001-42549 251564948 34 763123 1 1
2025-12-04 4 4 0001193125-25-308424 5013
2025-12-04 8-K 8-K 1.01,9.01 0001193125-25-308144 001-42549 251550167 34 448760 1 1
2025-12-03 424B4 424B4 0001193125-25-306986 333-291854 251547457 33 811172
2025-12-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003485 333-291854 251544873 33 1832
2025-12-02 S-1MEF S-1MEF 0001193125-25-305761 333-291905 251544858 33 201774 1 1
2025-12-01 CORRESP filename1.htm 0001193125-25-303153 11255
2025-12-01 CORRESP filename1.htm 0001193125-25-303150 9036
2025-12-01 S-1 S-1 0001193125-25-303114 333-291854 251537131 33 1291403 1 1
2025-12-01 8-K 8-K 2.02,9.01 0001193125-25-303104 001-42549 251537124 34 173660 1 1
2025-11-10 3 3 0001193125-25-274366 21173
2025-11-10 8-K 8-K 7.01,9.01 0001193125-25-274183 001-42549 251466098 34 222440 1 1
2025-10-29 DRS filename1.htm 0001193125-25-255705 377-08624 251428428 33 1022682
2025-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002310 005-95012 251379732 34 11733
2025-09-15 4/A 4/A 0001193125-25-203649 4884
2025-09-15 4/A 4/A 0001193125-25-203592 4928
2025-09-12 10-Q 10-Q 0000950170-25-114536 001-42549 251311711 34 7790367 1 1
2025-09-11 8-K 8-K 2.02,9.01 0000950170-25-114228 001-42549 251308709 34 496781 1 1
2025-09-08 4 4 0000950170-25-113637 21643
2025-09-08 4 4 0000950170-25-113631 6546
2025-09-08 4 4 0000950170-25-113628 4928
2025-09-08 4 4 0000950170-25-113627 6282
2025-09-08 4 4 0000950170-25-113623 4854
2025-09-08 3 3 0000950170-25-113617 18734
2025-09-04 8-K 8-K 5.07 0000950170-25-113058 001-42549 251294031 34 180262 1 1
2025-07-24 4 4 0000950170-25-098339 19294
2025-07-22 ARS ARS 0001193125-25-162556 001-42549 251140422 34 826900
2025-07-22 DEFA14A DEFA14A 0001193125-25-162549 001-42549 251140399 34 998666
2025-07-22 DEF 14A DEF 14A 0001193125-25-162541 001-42549 251140365 34 449016
2025-07-21 4 4 0000950170-25-097326 6468
2025-07-21 4 4 0000950170-25-097321 21402
2025-07-21 4 4 0000950170-25-097318 6460
2025-07-21 4 4 0000950170-25-097312 21139
2025-07-17 10-K 10-K 0000950170-25-096609 001-42549 251130725 34 12884461 1 1
2025-07-15 8-K 8-K 2.02,9.01 0000950170-25-095869 001-42549 251124889 34 604714 1 1
2025-06-12 3 3 0000950170-25-085423 3033
2025-06-06 8-K 8-K 5.02,9.01 0001193125-25-136269 001-42549 251028781 34 149838 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072853 005-95012 25955771 34 8562
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072595 005-95012 25952684 34 163106
2025-05-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001533 005-95012 25933279 34 11474
2025-04-17 10-Q 10-Q 0000950170-25-055319 001-42549 25847039 34 9775728 1 1
2025-04-14 8-K 8-K 2.02,9.01 0000950170-25-053715 001-42549 25836171 34 599733 1 1
2025-03-07 S-8 S-8 0001193125-25-049946 333-285652 25721058 33 117197
2025-03-07 8-K 8-K 1.01,3.03,5.02,5.03,9.01 0001193125-25-049896 001-42549 25720353 34 1426639 1 1
2025-03-06 3 3 0000950170-25-035079 4312
2025-03-06 3 3 0000950170-25-035065 5099
2025-03-06 3 3 0000950170-25-035063 5096
2025-03-06 3 3 0000950170-25-035058 4906
2025-03-06 3 3 0000950170-25-035054 5036
2025-03-06 3 3 0000950170-25-035052 5078
2025-03-06 3 3 0000950170-25-035050 7168
2025-03-06 3 3 0000950170-25-035047 3032
2025-03-06 3 3 0000950170-25-035045 2876
2025-03-06 3 3 0000950170-25-035044 3050
2025-03-06 3 3 0000950170-25-035042 3004
2025-03-06 3 3 0000950170-25-035035 2986
2025-03-06 424B4 424B4 0001193125-25-048462 333-284807 25715884 33 3181549
2025-03-06 CERT 8A_Cert_KMTS.pdf 0001354457-25-000184 001-42549 25713612 34 251294
2025-03-06 8-A12B 8-A12B 0001193125-25-047727 001-42549 25713498 34 14237
2025-03-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000581 333-284807 25713459 33 1838
2025-03-05 S-1MEF S-1MEF 0001193125-25-047580 333-285587 25713423 33 103143
2025-03-03 CORRESP filename1.htm 0001193125-25-044034 10353
2025-03-03 CORRESP filename1.htm 0001193125-25-044028 9291
2025-03-03 S-1/A S-1/A 0001193125-25-043885 333-284807 25696566 33 74556
2025-02-27 CORRESP filename1.htm 0001193125-25-039423 26752
2025-02-26 S-1/A S-1/A 0001193125-25-035754 333-284807 25665995 33 6237782
2025-02-10 S-1 S-1 0001193125-25-023649 333-284807 25606618 33 3776149
2025-02-04 DRSLTR filename1.htm 0000950123-25-000891 42207
2025-02-04 DRS/A filename1.htm 0000950123-25-000890 377-05412 25589685 33 3249044
2025-01-29 UPLOAD filename1.pdf 0000000000-25-000980 377-05412 49564
2025-01-17 DRSLTR filename1.htm 0000950123-25-000387 45999
2025-01-17 DRS/A filename1.htm 0000950123-25-000386 377-05412 25539650 33 3271732
2025-01-07 UPLOAD filename1.pdf 0000000000-25-000157 377-05412 59621
2024-12-11 DRSLTR filename1.htm 0000950123-24-012241 33113
2024-12-11 DRS/A filename1.htm 0000950123-24-012240 377-05412 241542483 33 2829899
2021-12-08 UPLOAD filename1.pdf 0000000000-21-014754 377-05412 44453
2021-11-23 DRSLTR filename1.htm 0000950123-21-015830 37613
2021-11-23 DRS/A filename1.htm 0000950123-21-015829 377-05412 211439015 33 3272431
2021-09-29 UPLOAD filename1.pdf 0000000000-21-011842 377-05412 51994
2021-08-25 DRS filename1.htm 0000950123-21-011871 377-05412 211207610 33 2512768

Latest XBRL company facts

One latest value per concept from companyfacts (210 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 59.56M 2026-09-11 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
dei EntityPublicFloat Entity Public Float USD 618.70M 2025-10-31 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 25.96M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 890,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 22.29M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 6.16M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2.45M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 3.17M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 33.86M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -471,000 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 859.50M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 4.92M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 9.52M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 9.52M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 408,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.59M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap Assets Assets USD 347.36M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap AssetsCurrent Assets, Current USD 226.27M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 415,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 68.56M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 244.70M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 68.89M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -31.15M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 1 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 100.00M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 59.27M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 59.27M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap CommonStockValue Common Stock, Value, Issued USD 59.27M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -44.34M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1.17M 2024-07-01 2024-07-31 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 13.47M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 72.50M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 2.50M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 166,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 11.99M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 6.66M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 35.38M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 137.64M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 5.52M 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 11.68M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 80.95M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 5.91M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6.16M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.56M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 125.96M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 306,000 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 198,000 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 591,000 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 10.66M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 1.84M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap Depreciation Depreciation USD 2.66M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.66M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.75 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.75 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.001 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2023-05-01 2024-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount EffectiveIncomeTaxRateReconciliationCrossBorderOtherAmount USD 503,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent EffectiveIncomeTaxRateReconciliationCrossBorderOtherPercent pure -0.004 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.051 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.003 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent pure 0.125 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 8.60M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap EquityMethodInvestments Equity Method Investments USD 5.00M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 251,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD -4.97M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ForeignEarningsRepatriated Foreign Earnings Repatriated USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -292,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -6.30M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap GrossProfit Gross Profit USD 17.50M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -116.15M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -44.04M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -15.17M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -92.78M 2025-05-01 2026-01-31 2026 Q3 10-Q 2026-03-17 0001193125-26-111205
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 24,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 50,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 22.15M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 4.72M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -28.42M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 3.56M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 6.66M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -155,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -4.11M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 395,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncomeTaxReconciliationTaxExemptIncome Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount USD -4.72M 2024-05-01 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap IncomeTaxReconciliationTaxSettlementsForeign Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Amount USD -16.41M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.88M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 48,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -4.73M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -190,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -2,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -246,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 1.93M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.10M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.13M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap LeaseCost Lease, Cost USD 421,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.88M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 43,000 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.59M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.42M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.48M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.35M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.74M 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap Liabilities Liabilities USD 125.00M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 347.36M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap LiabilitiesCurrent Liabilities, Current USD 48.27M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 72.50M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap LongTermInvestments Long-term Investments USD 45.79M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 0 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -253,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 22.50M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -21.35M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -32.30M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -44.09M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -942,000 2024-05-01 2025-01-31 2026 Q3 10-Q 2026-03-17 0001193125-26-111205
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -44.09M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -44.09M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingExpenses Operating Expenses USD 55.16M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -37.66M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingLeaseCost Operating Lease, Cost USD 263,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.58M 2025-12-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 23,000 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.93M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingLeasePayments Operating Lease, Payments USD 544,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.26M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.12 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 6.40M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.12M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 6.20M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD -253,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 306,000 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -272,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 855,000 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap PaymentForAdministrativeFees Payment for Administrative Fees USD 4.88M 2024-05-01 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 1.88M 2025-05-01 2025-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 3.19M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 415,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 5.00M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 13.02M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 8.34M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 12.32M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 4.52M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 2.37M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 149.29M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 75.00M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 103.40M 2024-05-01 2025-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.14M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -44.09M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 97.52M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 63.66M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock Receivable from Shareholders or Affiliates for Issuance of Capital Stock USD 100 2025-01-31 2025 Q3 10-Q 2025-04-17 0000950170-25-055319
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 15.41M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 46.40M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 6.80M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap RestrictedCash Restricted Cash USD 334,000 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 334,000 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 1.01M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -695.95M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 30.97M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.61M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 48.36M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 9.52M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 73,578 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 17.93 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 779,832 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 20.75 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 2.83M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 18.71 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 379,126 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 15.72 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-05-01 2024-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.59 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 13,589 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.66M 2024-05-01 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 10.2 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 25.66M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.42M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 17.04 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 11.60M 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.66M 2025-07-31 2025 Q1 10-Q 2025-09-12 0000950170-25-114536
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 17.07 2025-07-31 2025 Q1 10-Q 2025-09-12 0000950170-25-114536
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 17 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 17 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 17.04 2024-05-01 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap ShortTermInvestments Short-term Investments USD 130.35M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 222.36M 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 67,059 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.30M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 148.29M 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 177.11M 2024-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2025-04-30 2025 FY 10-K 2025-07-17 0000950170-25-096609
us-gaap TenantImprovements Tenant Improvements USD 786,000 2024-04-30 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 863,000 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 44,000 2025-05-01 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 863,000 2026-04-30 2026 FY 10-K 2026-07-14 0001193125-26-303397
us-gaap VariableLeaseCost Variable Lease, Cost USD 158,000 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 1.37M 2026-04-30 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 58.57M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 58.57M 2026-05-01 2026-07-31 2026 Q1 10-Q 2026-09-14 0001193125-26-390766

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →